drugset / Trial / NCT05859971
ICG and SLN Mapping
Phase 0
Completed
10 enrolled
University of Wisconsin, Madison
National Cancer Institute (NCI) · collabOnLume Inc. · collab
NaSingle-groupOpen-labelDiagnostic
Summary
The purpose of this research study is to assess the feasibility of using a different dye and imaging device, indocyanine green (ICG)-fluorescent imaging through the Asimov Imaging Platform, to perform sentinel lymph node biopsy. Participants in this research study will be undergoing a sentinel lymph node biopsy as part of surgical treatment for breast cancer. Active participation will last through the post-operative visit.
Timeline
- Start
- 2023-04-13
- Primary completion
- 2023-06-01
- Completion
- 2023-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Indocyanine Green | Diagnostic / imaging agent | 2 ml | Intramuscular |
| Subject | Indocyanine Green | Diagnostic / imaging agent | 5 mg | Intramuscular |
| Background | Technegas | Diagnostic / imaging agent | — | — |
| Background | isosulfan blue dye | Diagnostic / imaging agent | — | Other |